» Articles » PMID: 16723595

Efficacy of Voriconazole in a Guinea Pig Model of Invasive Trichosporonosis

Overview
Specialty Pharmacology
Date 2006 May 26
PMID 16723595
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

We have evaluated the efficacy of voriconazole (VRC) in a systemic infection by Trichosporon asahii in immunosuppressed guinea pigs. VRC was more effective than amphotericin B in prolonging survival and reducing tissue burden. The best results were obtained with VRC at 10 mg/kg of body weight/day.

Citing Articles

Case report: Diagnostic and therapeutic challenges of fungal endocarditis by in a child with congenital heart defects.

Baptistella A, Rossato A, de Gusmao B, Cunha C, Trafane L, Colbachini P Front Pediatr. 2023; 11:1200215.

PMID: 37868264 PMC: 10588001. DOI: 10.3389/fped.2023.1200215.


First Report on Concomitant Infection of Nasal Myiasis and Trichosporonosis in an Uncontrolled Diabetic Patient: Case Report.

Tyagi A, Suji P, Kumar A, Varshney S, Mohanty A, Gupta P Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 2):810-812.

PMID: 36452667 PMC: 9702439. DOI: 10.1007/s12070-020-01850-9.


A novel silkworm infection model with fluorescence imaging using transgenic Trichosporon asahii expressing eGFP.

Matsumoto Y, Yamazaki H, Yamasaki Y, Tateyama Y, Yamada T, Sugita T Sci Rep. 2020; 10(1):10991.

PMID: 32620930 PMC: 7335072. DOI: 10.1038/s41598-020-67841-6.


Epidemiology and Outcome of Trichosporon Fungemia: A Review of 185 Reported Cases From 1975 to 2014.

Liao Y, Lu X, Yang S, Luo Y, Chen Q, Yang R Open Forum Infect Dis. 2015; 2(4):ofv141.

PMID: 26566536 PMC: 4630454. DOI: 10.1093/ofid/ofv141.


On and Under the Skin: Emerging Basidiomycetous Yeast Infections Caused by Trichosporon Species.

Marine M, Brown N, Riano-Pachon D, Goldman G PLoS Pathog. 2015; 11(7):e1004982.

PMID: 26226483 PMC: 4520462. DOI: 10.1371/journal.ppat.1004982.


References
1.
Chandrasekar P, Cutright J, Manavathu E . Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model. J Antimicrob Chemother. 2000; 45(5):673-6. DOI: 10.1093/jac/45.5.673. View

2.
Cawley M, Braxton G, Haith L, Reilly K, Guilday R, Patton M . Trichosporon beigelii infection: experience in a regional burn center. Burns. 2000; 26(5):483-6. DOI: 10.1016/s0305-4179(99)00181-3. View

3.
Uzun O, Arikan S, Kocagoz S, Sancak B, Unal S . Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. Diagn Microbiol Infect Dis. 2000; 38(2):101-7. DOI: 10.1016/s0732-8893(00)00177-2. View

4.
Moretti-Branchini M, Fukushima K, Schreiber A, Nishimura K, Papaiordanou P, Trabasso P . Trichosporon species infection in bone marrow transplanted patients. Diagn Microbiol Infect Dis. 2001; 39(3):161-4. DOI: 10.1016/s0732-8893(01)00215-2. View

5.
Ebright J, Fairfax M, Vazquez J . Trichosporon asahii, a non-Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin Infect Dis. 2001; 33(5):E28-30. DOI: 10.1086/322640. View